135 related articles for article (PubMed ID: 30827400)
1. Duration of immunity for an inactivated Mycoplasma hyorhinis vaccine in pigs.
Martinson B; Zoghby W; Barrett K; Bryson L; Kroll J
Vet Microbiol; 2019 Mar; 230():273-277. PubMed ID: 30827400
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of an inactivated Mycoplasma hyorhinis vaccine in pigs.
Martinson B; Zoghby W; Barrett K; Bryson L; Christmas R; Minion FC; Kroll J
Vaccine; 2018 Jan; 36(3):408-412. PubMed ID: 29221894
[TBL] [Abstract][Full Text] [Related]
3. Age susceptibility of caesarian derived colostrum deprived pigs to Mycoplasma hyorhinis challenge.
Martinson B; Minion FC; Kroll J; Hermann J
Vet Microbiol; 2017 Oct; 210():147-152. PubMed ID: 29103684
[TBL] [Abstract][Full Text] [Related]
4. Efficacy in pigs of a new inactivated vaccine combining porcine circovirus type 2 and Mycoplasma hyorhinis.
Wei YW; Zhu HZ; Huang LP; Xia DL; Wu HL; Bian HQ; Feng L; Liu CM
Vet Microbiol; 2020 Mar; 242():108588. PubMed ID: 32122592
[TBL] [Abstract][Full Text] [Related]
5. Development and optimization of a cell-associated challenge model for
Martinson B; Minion FC; Jordan D
Can J Vet Res; 2018 Jan; 82(1):12-23. PubMed ID: 29382965
[No Abstract] [Full Text] [Related]
6. Reduction of mycoplasmal lesions and clinical signs by vaccination against Mycoplasma hyorhinis.
Lee JA; Hwang MA; Han JH; Cho EH; Lee JB; Park SY; Song CS; Choi IS; Lee SW
Vet Immunol Immunopathol; 2018 Feb; 196():14-17. PubMed ID: 29695319
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of colonization, variable lipoprotein-based serological response, and cellular immune response of Mycoplasma hyorhinis in experimentally infected swine.
Merodio M; McDaniel A; Poonsuk K; Magtoto R; Ferreyra FSM; Meiroz-De-Souza-Almeida H; Ross RF; Gimenez-Lirola L; Arruda B; Derscheid R
Vet Microbiol; 2021 Sep; 260():109162. PubMed ID: 34217902
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Mycoplasma hyopneumoniae inactivated vaccine in pigs under field conditions.
Okada M; Sakano T; Senna K; Maruyama T; Murofushi J; Okonogi H; Sato S
J Vet Med Sci; 1999 Oct; 61(10):1131-5. PubMed ID: 10563291
[TBL] [Abstract][Full Text] [Related]
9. A p37-based ELISA used to monitor anti- Mycoplasma hyorhinis IgG in serum from pigs immunized with inactivated M. hyorhinis vaccines.
Bumgardner EA; Bey RF; Lawrence PK
J Vet Diagn Invest; 2018 Sep; 30(5):755-759. PubMed ID: 29938600
[TBL] [Abstract][Full Text] [Related]
10. Virulence and Inoculation Route Influence the Consequences of
Wang J; Hua L; Gan Y; Yuan T; Li L; Yu Y; Xie Q; Olaniran AO; Chiliza TE; Shao G; Feng Z; Pillay B; Xiong Q
Microbiol Spectr; 2022 Jun; 10(3):e0249321. PubMed ID: 35446115
[TBL] [Abstract][Full Text] [Related]
11. Vaccination of piglets at 1 week of age with an inactivated Mycoplasma hyopneumoniae vaccine reduces lung lesions and improves average daily gain in body weight.
Wilson S; Van Brussel L; Saunders G; Taylor L; Zimmermann L; Heinritzi K; Ritzmann M; Banholzer E; Eddicks M
Vaccine; 2012 Dec; 30(52):7625-9. PubMed ID: 23084853
[TBL] [Abstract][Full Text] [Related]
12. Field study on the efficacy of two different vaccination schedules with HYORESP in a Mycoplasma hyopneumoniae-infected commercial pig unit.
Kyriakis SC; Alexopoulos C; Vlemmas J; Sarris K; Lekkas S; Koutsoviti-Papadopoulou M; Saoulidis K
J Vet Med B Infect Dis Vet Public Health; 2001 Nov; 48(9):675-84. PubMed ID: 11765803
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of antibody response and bacterial shedding of Mycoplasma hyorhinis and M. hyosynoviae in oral fluids from experimentally inoculated pigs.
Magtoto PD; Arruda BL; Magtoto RL; Mora-Díaz JC; Opulencia RB; Baum DH; Zimmerman JJ; Giménez-Lirola LG
Vet Microbiol; 2024 Mar; 290():109999. PubMed ID: 38280306
[TBL] [Abstract][Full Text] [Related]
14. Aerosol vaccination of pigs against Mycoplasma hyopneumoniae infection.
Murphy D; Van Alstine WG; Clark LK; Albregts S; Knox K
Am J Vet Res; 1993 Nov; 54(11):1874-80. PubMed ID: 8291766
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis comparing the effect of vaccines against Mycoplasma hyopneumoniae on daily weight gain in pigs.
Jensen CS; Ersbøll AK; Nielsen JP
Prev Vet Med; 2002 Jul; 54(3):265-78. PubMed ID: 12114013
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a new bivalent vaccine of porcine circovirus type 2 and Mycoplasma hyopneumoniae (Fostera™ PCV MH) under experimental conditions.
Park C; Jeong J; Choi K; Chae C
Vaccine; 2016 Jan; 34(2):270-275. PubMed ID: 26626212
[TBL] [Abstract][Full Text] [Related]
17. Early detection and differential serodiagnosis of Mycoplasma hyorhinis and Mycoplasma hyosynoviae infections under experimental conditions.
Giménez-Lirola LG; Meiroz-De-Souza-Almeida H; Magtoto RL; McDaniel AJ; Merodio MM; Matias Ferreyra FS; Poonsuk K; Gatto IRH; Baum DH; Ross RF; Arruda PHE; Schwartz KJ; Zimmerman JJ; Derscheid RJ; Arruda BL
PLoS One; 2019; 14(10):e0223459. PubMed ID: 31589633
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of oral microencapsulated Mycoplasma hyopneumoniae vaccine prepared by co-spray drying method.
Lin JH; Weng CN; Liao CW; Yeh KS; Pan MJ
J Vet Med Sci; 2003 Jan; 65(1):69-74. PubMed ID: 12576707
[TBL] [Abstract][Full Text] [Related]
19. Mycoplasma hyorhinis and Mycoplasma hyosynoviae dual detection patterns in dams and piglets.
Roos LR; Surendran Nair M; Rendahl AK; Pieters M
PLoS One; 2019; 14(1):e0209975. PubMed ID: 30605453
[TBL] [Abstract][Full Text] [Related]
20. Detection of Mycoplasma hyorhinis and Mycoplasma hyosynoviae in oral fluids and correlation with pig lameness scores.
Pillman D; Surendran Nair M; Schwartz J; Pieters M
Vet Microbiol; 2019 Dec; 239():108448. PubMed ID: 31767090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
